Chevy Chase Trust Holdings LLC Decreases Holdings in HCA Healthcare, Inc. $HCA

Chevy Chase Trust Holdings LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 8.6% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 83,664 shares of the company’s stock after selling 7,907 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in HCA Healthcare were worth $35,658,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the company. Sovran Advisors LLC increased its position in shares of HCA Healthcare by 1.0% during the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after purchasing an additional 22 shares during the last quarter. Centerpoint Advisors LLC grew its position in HCA Healthcare by 11.0% during the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after buying an additional 22 shares during the period. Cary Street Partners Financial LLC raised its position in HCA Healthcare by 3.9% in the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after acquiring an additional 22 shares during the period. Angeles Wealth Management LLC grew its position in shares of HCA Healthcare by 2.4% during the 3rd quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after acquiring an additional 24 shares during the period. Finally, One Capital Management LLC raised its holdings in HCA Healthcare by 1.1% in the 3rd quarter. One Capital Management LLC now owns 2,250 shares of the company’s stock worth $959,000 after purchasing an additional 24 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on HCA. Oppenheimer raised their price objective on HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Truist Financial increased their target price on shares of HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Barclays lifted their target price on shares of HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a research note on Wednesday, January 28th. Finally, UBS Group increased their price target on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. Sixteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $537.73.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $533.39 on Monday. The firm has a market cap of $119.28 billion, a price-to-earnings ratio of 18.79, a P/E/G ratio of 1.64 and a beta of 1.34. The firm has a fifty day moving average price of $507.05 and a 200 day moving average price of $470.48. HCA Healthcare, Inc. has a fifty-two week low of $313.21 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the previous year, the company earned $6.22 EPS. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. The trade was a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 over the last quarter. 1.30% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.